Europe Launches 2017 with $3.4 Billion Investment in First-Quarter Pharmaceutical-Biotech Construction Starts

SUGAR LAND--January 13, 2017--Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas)--Much like its North American brethren, the European Pharmaceutical & Biotech Industry, better described as the Life Science Industry, includes the development and production of pharmaceuticals, biologicals, medical devices and cosmetics. Continuing to return a healthy capital expenditure investment profile, Europe's volume of project activity continues to impress.

Within this article: Details on some of the highest-valued life-science projects set to begin construction this year in Europe, including those from major companies such as CSL Behring GmbH and Abcam plc.